Anneke M. Westermann
Department of Medical Oncology
Academic Medical Center
Amsterdam
Netherlands
Name/email consistency: high
- First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma. Westermann, A.M., Jones, E.L., Schem, B.C., van der Steen-Banasik, E.M., Koper, P., Mella, O., Uitterhoeve, A.L., de Wit, R., van der Velden, J., Burger, C., van der Wilt, C.L., Dahl, O., Prosnitz, L.R., van der Zee, J. Cancer (2005)
- Sequence-dependent toxicity profile in modified FAMTX (fluorouracil-adriamycin-methotrexate) chemotherapy with lenograstim support for advanced gastric cancer: a feasibility study. Westermann, A.M., Taal, B.G., Swart, M., Boot, H., Craanen, M., Gerritsen, W.R. Pharmacol. Res. (2000)
- Feasibility and pharmacokinetics of intraperitoneal suramin in advanced malignancy. Westermann, A.M., Dubbelman, R., Baars, J.P., Moolenaar, W.H., Beijnen, J.H., Rodenhuis, S. Cancer Chemother. Pharmacol. (2000)
- At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies. Westermann, A.M., Holtkamp, M.M., Linthorst, G.A., van Leeuwen, L., Willemse, E.J., van Dijk, W.C., Nooijen, W.J., Baars, J.W., Schornagel, J.H., Rodenhuis, S. Ann. Oncol. (1999)